Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab
Immune-checkpoint-inhibitors (ICPIs) represent a novel class of immunotherapy against several malignancies. These agents are associated with several “immune-mediated” adverse effects, but the reported renal toxicity of ICPIs is less well defined. We present the case of a 60-year-old man with a histo...
Saved in:
Main Authors: | Panagiotis I. Georgianos, Vasilios Vaios, Eleni Leontaridou, Georgia Karayannopoulou, Triantafyllia Koletsa, Athanasios Sioulis, Elias V. Balaskas, Pantelis E. Zebekakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2019/3614980 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy
by: Antonio Faieta, et al.
Published: (2021-01-01) -
Gastric Carcinoma with Osteoclast-Like Giant Cells Coexisting with Gastrointestinal Spindle Cell Tumor
by: Christos Poulios, et al.
Published: (2013-01-01) -
Allergic Interstitial Nephritis Manifesting as a Striated Nephrogram
by: Irfan Moinuddin, et al.
Published: (2015-01-01) -
Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
by: Payaswini Vasanth, et al.
Published: (2016-01-01) -
Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
by: Tetsuya Danno, et al.
Published: (2021-01-01)